Shilpa Medicare Can Make 100-200 Million Doses of Covid-19 Shot, Says Executive; Shares Jump 9.2%


Drugmaker Shilpa Medicare Ltd has the production capacity to make 100-200 million doses of a recombinant vaccine for COVID-19, a company executive told Reuters on Wednesday.

The company’s shares jumped as much as 9.2% on India’s National Stock Exchange following the news.

Read all the Latest News and Breaking News here